FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4244009669> ?p ?o ?g. }

• W4244009669 endingPage "2707" @default.
• W4244009669 startingPage "2707" @default.
• W4244009669 abstract "Abstract Approximately 45% of colorectal cancers harbor mutations in the KRAS gene, resulting in constitutive activation of RAS signaling through effector proteins, primarily RAF and PI3K. Members of the RAS family are GTPases that function as a molecular switch, cycling between inactive (GDP-bound) and active (GTP-bound) states in cells to regulate proliferation and survival. Constitutive signaling from mutant RAS drives tumorigenesis, in part, by deregulation of the cell cycle, resulting in increased proliferation (mitosis) and decreased apoptosis of tumor cells. From an extensive medicinal chemistry/screening campaign, we identified a novel compound class that potently and selectively inhibits the growth of tumor cell lines harboring constitutively activated RAS by a mechanism involving the disruption of RAS nucleotide loading, blockage of effector activation, and consequent inhibition of signaling. A prototype of the class, MCI-062, inhibits the growth of KRAS-driven (HCT-116) colon tumor cells with low nanomolar IC50 values, while RAS-independent (HT-29) colon tumor cells harboring the BRAF V600E mutation, are essentially insensitive. A strong correlation was measured among a larger panel of tumor cell lines between potency to inhibit tumor cell growth and levels of activated RAS. The growth inhibitory effects of MCI-062 were sustained and irreversible as demonstrated by colony formation and apoptosis assays. MCI-062 treatment of HCT-116 colon tumor cells reduced levels of activated RAS and RAS-mediated signaling as measured by GST-RBD pulldown assays and phospho-specific immunoblotting. Within the same concentration range, MCI-062 induced mitotic arrest as measured by cell cycle analysis of DNA content and phospho-histone H3B immunofluorescence. Further analysis revealed that MCI-062 interfered with localization of the mitosis-inducing protein, PLK1 to kinetochores and decreased nuclear localization of its substrate, Cdc25C, a downstream target of RAS-RAF signaling involved in both mitotic entry and exit checkpoints. In vivo testing of MCI-062 in a syngeneic mouse model of KRAS-driven colon cancer (CT-26) demonstrated that MCI-062 engages its molecular target, depleting GTP-RAS and suppressing activation of the MAPK signal transduction pathway, and inhibiting tumor growth. MCI-062 also suppresses PD-L1 expression and activates anti-tumor immunity, which may contribute to its antitumor activity and suggests potential benefits of combining with immunotherapy. From these studies, we have identified a novel class of RAS inhibitors that potently and selectively inhibits RAS-driven tumor growth by disrupting downstream signaling, leading to cell cycle arrest and apoptosis. These findings support further development of MCI-062 for treatment of RAS-driven colorectal and other cancers. Funding provided by NCI grants R01CA131378, R01CA148817, R01CA197147, and R01CA155638. Citation Format: Adam B. Keeton, Antonio Ward, Xi Chen, Jacob Valiyaveettil, Bing Zhu, Veronica Ramirez-Alcantara, Yulia Maxuitenko, Kristy Berry, Tyler E. Mattox, Michael R. Boyd, Gary A. Piazza. A novel RAS inhibitor, MCI-062, inhibits colon tumor growth in vivo and activates antitumor immunity [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2707." @default.
• W4244009669 created "2022-05-12" @default.
• W4244009669 creator A5003328681 @default.
• W4244009669 creator A5008171524 @default.
• W4244009669 creator A5008726864 @default.
• W4244009669 creator A5021533593 @default.
• W4244009669 creator A5034358215 @default.
• W4244009669 creator A5036206395 @default.
• W4244009669 creator A5036693985 @default.
• W4244009669 creator A5037915403 @default.
• W4244009669 creator A5062264366 @default.
• W4244009669 creator A5071802884 @default.
• W4244009669 creator A5086841234 @default.
• W4244009669 date "2019-07-01" @default.
• W4244009669 modified "2023-10-18" @default.
• W4244009669 title "Abstract 2707: A novel RAS inhibitor, MCI-062, inhibits colon tumor growth in vivo and activates antitumor immunity" @default.
• W4244009669 doi "https://doi.org/10.1158/1538-7445.am2019-2707" @default.
• W4244009669 hasPublicationYear "2019" @default.
• W4244009669 type Work @default.
• W4244009669 citedByCount "5" @default.
• W4244009669 countsByYear W42440096692020 @default.
• W4244009669 countsByYear W42440096692022 @default.
• W4244009669 countsByYear W42440096692023 @default.
• W4244009669 crossrefType "journal-article" @default.
• W4244009669 hasAuthorship W4244009669A5003328681 @default.
• W4244009669 hasAuthorship W4244009669A5008171524 @default.
• W4244009669 hasAuthorship W4244009669A5008726864 @default.
• W4244009669 hasAuthorship W4244009669A5021533593 @default.
• W4244009669 hasAuthorship W4244009669A5034358215 @default.
• W4244009669 hasAuthorship W4244009669A5036206395 @default.
• W4244009669 hasAuthorship W4244009669A5036693985 @default.
• W4244009669 hasAuthorship W4244009669A5037915403 @default.
• W4244009669 hasAuthorship W4244009669A5062264366 @default.
• W4244009669 hasAuthorship W4244009669A5071802884 @default.
• W4244009669 hasAuthorship W4244009669A5086841234 @default.
• W4244009669 hasConcept C105696609 @default.
• W4244009669 hasConcept C121608353 @default.
• W4244009669 hasConcept C185592680 @default.
• W4244009669 hasConcept C190283241 @default.
• W4244009669 hasConcept C2779707156 @default.
• W4244009669 hasConcept C2781187634 @default.
• W4244009669 hasConcept C29537977 @default.
• W4244009669 hasConcept C502942594 @default.
• W4244009669 hasConcept C51785407 @default.
• W4244009669 hasConcept C526805850 @default.
• W4244009669 hasConcept C54355233 @default.
• W4244009669 hasConcept C55493867 @default.
• W4244009669 hasConcept C555283112 @default.
• W4244009669 hasConcept C62112901 @default.
• W4244009669 hasConcept C62478195 @default.
• W4244009669 hasConcept C86554907 @default.
• W4244009669 hasConcept C86803240 @default.
• W4244009669 hasConcept C93304396 @default.
• W4244009669 hasConcept C95444343 @default.
• W4244009669 hasConceptScore W4244009669C105696609 @default.
• W4244009669 hasConceptScore W4244009669C121608353 @default.
• W4244009669 hasConceptScore W4244009669C185592680 @default.
• W4244009669 hasConceptScore W4244009669C190283241 @default.
• W4244009669 hasConceptScore W4244009669C2779707156 @default.
• W4244009669 hasConceptScore W4244009669C2781187634 @default.
• W4244009669 hasConceptScore W4244009669C29537977 @default.
• W4244009669 hasConceptScore W4244009669C502942594 @default.
• W4244009669 hasConceptScore W4244009669C51785407 @default.
• W4244009669 hasConceptScore W4244009669C526805850 @default.
• W4244009669 hasConceptScore W4244009669C54355233 @default.
• W4244009669 hasConceptScore W4244009669C55493867 @default.
• W4244009669 hasConceptScore W4244009669C555283112 @default.
• W4244009669 hasConceptScore W4244009669C62112901 @default.
• W4244009669 hasConceptScore W4244009669C62478195 @default.
• W4244009669 hasConceptScore W4244009669C86554907 @default.
• W4244009669 hasConceptScore W4244009669C86803240 @default.
• W4244009669 hasConceptScore W4244009669C93304396 @default.
• W4244009669 hasConceptScore W4244009669C95444343 @default.
• W4244009669 hasIssue "13_Supplement" @default.
• W4244009669 hasLocation W42440096691 @default.
• W4244009669 hasOpenAccess W4244009669 @default.
• W4244009669 hasPrimaryLocation W42440096691 @default.
• W4244009669 hasRelatedWork W2145402444 @default.
• W4244009669 hasRelatedWork W2147266699 @default.
• W4244009669 hasRelatedWork W2350294409 @default.
• W4244009669 hasRelatedWork W2351136637 @default.
• W4244009669 hasRelatedWork W2358789216 @default.
• W4244009669 hasRelatedWork W2376744432 @default.
• W4244009669 hasRelatedWork W2379033026 @default.
• W4244009669 hasRelatedWork W2379203010 @default.
• W4244009669 hasRelatedWork W3032847486 @default.
• W4244009669 hasRelatedWork W4283782187 @default.
• W4244009669 hasVolume "79" @default.
• W4244009669 isParatext "false" @default.
• W4244009669 isRetracted "false" @default.
• W4244009669 workType "article" @default.